|
1
|
Chen S, Li M, Li R, Cao J, Wu Q, Zhou T,
Cai Z and Li N: Clear cell sarcoma of the kidney in children: A
clinopathologic analysis of three cases. Int J Clin Exp Pathol.
13:771–777. 2020.PubMed/NCBI
|
|
2
|
Aw SJ and Chang KTE: Clear cell sarcoma of
the kidney. Arch Pathol Lab Med. 143:1022–1026. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gooskens SL, Furtwängler R, Vujanic GM,
Dome JS, Graf N and van den Heuvel-Eibrink MM: Clear cell sarcoma
of the kidney: A review. Eur J Cancer. 48:2219–2226.
2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Argani P, Perlman EJ, Breslow NE, Browning
NG, Green DM, D'Angio GJ and Beckwith JB: Clear cell sarcoma of the
kidney: A review of 351 cases from the national wilms tumor study
group pathology center. Am J Surg Pathol. 24:4–18. 2000.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ng A, Jenkinson H, Morland B and Grundy R:
Clear cell sarcoma: A dilemma on pathological staging and clinical
management. Pediatr Hematol Oncol. 22:257–261. 2005.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kusumakumary P, Mathews A, James FV,
Chellam VG, Hariharan S, Varma RR and Nair MK: Clear cell sarcoma
kidney: Clinical features and outcome. Pediatr Hematol Oncol.
16:169–174. 1999.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Furtwängler R, Gooskens SL, van Tinteren
H, de Kraker J, Schleiermacher G, Bergeron C, de Camargo B, Acha T,
Godzinski J, Sandstedt B, et al: Clear cell sarcomas of the kidney
registered on international society of pediatric oncology (SIOP)
93-01 and SIOP 2001 protocols: A report of the SIOP renal tumour
study group. Eur J Cancer. 49:3497–3506. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jackson TJ, Williams RD, Brok J, Chowdhury
T, Ronghe M, Powis M, Pritchard-Jones K and Vujanić GM: Children's
Cancer and Leukaemia Group (CCLG) Renal Tumours Group. The
diagnostic accuracy and clinical utility of pediatric renal tumor
biopsy: Report of the UK experience in the SIOP UK WT 2001 trial.
Pediatr Blood Cancer. 66(e27627)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Friesenbichler W, Lüftinger R, Kropshofer
G, Henkel M, Amann G, Furtwängler R, Graf N and Kager L: Clear cell
sarcoma of the kidney in Austrian children: Long-term survival
after relapse. Pediatr Blood Cancer. 68(e28860)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Charafe E, Penault-Llorca F,
Mathoulin-Portier MP, Bladou F, Delpéro JR, Prime-Guitton C,
Vieillefond A, Xerri L and Hassoun J: Clear cell sarcoma of the
kidney relapsing after 10 years of asymptomatic evolution. Ann
Pathol. 17:400–402. 1997.PubMed/NCBI(In French).
|
|
11
|
Zhang Y, Chu Q, Ma Y, Miao C and Diao JJ:
Overall survival nomogram and relapse-related factors of clear cell
sarcoma of the kidney: A study based on published patients. Front
Pediatr. 10(943141)2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gooskens SL, Graf N, Furtwängler R,
Spreafico F, Bergeron C, Ramírez-Villar GL, Godzinski J, Rübe C,
Janssens GO, Vujanic GM, et al: Position paper: Rationale for the
treatment of children with CCSK in the UMBRELLA SIOP-RTSG 2016
protocol. Nat Rev Urol. 15:309–319. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Astolfi A, Fiore M, Melchionda F, Indio V,
Bertuccio SN and Pession A: BCOR involvement in cancer.
Epigenomics. 11:835–855. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Morgan E and Kidd JM: Undifferentiated
sarcoma of the kidney: A tumor of childhood with histopathologic
and clinical characteristics distinct from Wilms' tumor. Cancer.
42:1916–1921. 1978.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Drut R and Pomar M: Cytologic
characteristics of clear-cell sarcoma of the kidney (CCSK) in
fine-needle aspiration biopsy (FNAB): A report of 4 cases. Diagn
Cytopathol. 7:611–614. 1991.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Fiore M, Taddia A, Indio V, Bertuccio SN,
Messelodi D, Serravalle S, Bandini J, Spreafico F, Perotti D,
Collini P, et al: Molecular signature of biological aggressiveness
in clear cell sarcoma of the kidney (CCSK). Int J Mol Sci.
24(3743)2023.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wong MK, Ng CCY, Kuick CH, Aw SJ,
Rajasegaran V, Lim JQ, Sudhanshi J, Loh E, Yin M, Ma J, et al:
Clear cell sarcomas of the kidney are characterised by BCOR gene
abnormalities, including exon 15 internal tandem duplications and
BCOR-CCNB3 gene fusion. Histopathology. 72:320–329. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kao YC, Sung YS, Zhang L, Huang SC, Argani
P, Chung CT, Graf NS, Wright DC, Kellie SJ, Agaram NP, et al:
Recurrent BCOR internal tandem duplication and YWHAE-NUTM2B fusions
in soft tissue undifferentiated round cell sarcoma of infancy:
Overlapping genetic features with clear cell sarcoma of kidney. Am
J Surg Pathol. 40:1009–1020. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ueno-Yokohata H, Okita H, Nakasato K,
Akimoto S, Hata J, Koshinaga T, Fukuzawa M and Kiyokawa N:
Consistent in-frame internal tandem duplications of BCOR
characterize clear cell sarcoma of the kidney. Nat Genet.
47:861–863. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Singh V, Gupta K, Saraswati A, Peters NJ
and Trehan A: Role of cyclin D1 and BCOR immunohistochemistry in
differentiating clear cell sarcoma of kidney from its mimics. J
Pediatr Hematol Oncol. 43:294–300. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang M, Yao X, Guan X, Jia C, Zhang R,
Wang H, Guo Y, Ni X, Yu Y and He L: Clinical relevance of BCOR
internal tandem duplication and TP53 aberration in clear cell
sarcoma of the kidney. Hum Pathol. 134:45–55. 2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kenny C, Bausenwein S, Lazaro A,
Furtwängler R, Gooskens SL, van den Heuvel Eibrink M, Vokuhl C,
Leuschner I, Graf N, Gessler M and O'Sullivan MJ: Mutually
exclusive BCOR internal tandem duplications and YWHAE-NUTM2 fusions
in clear cell sarcoma of kidney: Not the full story. J Pathol.
238:617–620. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li X, Wang C, Wang S, Hu Y, Jin S, Liu O,
Gou R, Nie X, Liu J and Lin B: YWHAE as an HE4 interacting protein
can influence the malignant behaviour of ovarian cancer by
regulating the PI3K/AKT and MAPK pathways. Cancer Cell Int.
21(302)2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yang YF, Lee YC, Wang YY, Wang CH, Hou MF
and Yuan SF: YWHAE promotes proliferation, metastasis, and
chemoresistance in breast cancer cells. Kaohsiung J Med Sci.
35:408–416. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhao J, Xu H, Duan Z, Chen X, Ao Z, Chen
Y, Ruan Y and Ni M: miR-31-5p regulates 14-3-3 ɛ to inhibit
prostate cancer 22RV1 cell survival and proliferation via
PI3K/AKT/Bcl-2 signaling pathway. Cancer Manag Res. 12:6679–6694.
2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yan L, Gu H, Li J, Xu M, Liu T, Shen Y,
Chen B and Zhang G: RKIP and 14-3-3ε exert an opposite effect on
human gastric cancer cells SGC7901 by regulating the ERK/MAPK
pathway differently. Dig Dis Sci. 58:389–396. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Gooskens SL, Kenny C, Lazaro A, O'Meara E,
van Tinteren H, Spreafico F, Vujanic G, Leuschner I,
Coulomb-L'Herminé A, Perotti D, et al: The clinical phenotype of
YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney.
Genes Chromosomes Cancer. 55:143–147. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kenny C, McDonagh N, Lazaro A, O'Meara E,
Klinger R, O'Connor D, Roche F, Hokamp K and O'Sullivan MJ:
Dysregulated mitogen-activated protein kinase signalling as an
oncogenic basis for clear cell sarcoma of the kidney. J Pathol.
244:334–345. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ali Z, Haroon Khan A, Rehman U, Faisal M,
Ahmad IN, Mamoon N, Nasir H and Hameed Z: Is TLE1 expression
limited to synovial sarcoma? Our experience at Shifa International
Hospital, Pakistan. Cureus. 11(e6259)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Bergeron BP, Barnett KR, Bhattarai KR,
Mobley RJ, Hansen BS, Brown A, Kodali K, High AA, Jeha S, Pui CH,
et al: Mutual antagonism between glucocorticoid and canonical Wnt
signaling pathways in B-cell acute lymphoblastic leukemia. Blood
Adv. 7:4107–4111. 2023.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Hasbay B and kayaselCuk F: Expression of
TLE-1 in gastrointestinal stromal tumour and its relationship to
clinicopathological parameters. J Coll Physicians Surg Pak.
33:286–291. 2023.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Milman T, Eiger-Moscovich M, Henry RK, Ida
CM, Ruben M, Shields CL, Lally SE, Penne RB, Stefanyszyn MA, Bilyk
JR, et al: Cyclin D1 expression and molecular genetic findings in
periocular histiocytoses and neoplasms of macrophage-dendritic cell
lineage. Am J Ophthalmol. 242:36–51. 2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Mirkovic J, Calicchio M, Fletcher CD and
Perez-Atayde AR: Diffuse and strong cyclin D1 immunoreactivity in
clear cell sarcoma of the kidney. Histopathology. 67:306–312.
2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Uddin N, Minhas K, Abdul-Ghafar J, Ahmed A
and Ahmad Z: Expression of cyclin D1 in clear cell sarcoma of
kidney. Is it useful in differentiating it from its histological
mimics? Diagn Pathol. 14(13)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Narumi S, Muroya K, Abe Y, Yasui M,
Asakura Y, Adachi M and Hasegawa T: TSHR mutations as a cause of
congenital hypothyroidism in Japan: A population-based genetic
epidemiology study. J Clin Endocrinol Metab. 94:1317–1323.
2009.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wu Z, Xi Z, Xiao Y, Zhao X, Li J, Feng N,
Hu L, Zheng R, Zhang N, Wang S and Huang T: TSH-TSHR axis promotes
tumor immune evasion. J Immunother Cancer.
10(e004049)2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Muetze S, Kapagerof A, Vlachopoulos L,
Eggermann T, Kaufmann P, Zerres K, Rath W and Rudnik-Schoeneborn S:
Mutation analysis of the growth factor genes PlGF, Flt1, IGF-I, and
IGF-IR in intrauterine growth restriction with abnormal placental
blood flow. J Matern Fetal Neonatal Med. 23:142–147.
2010.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Sazonova O, Zhao Y, Nürnberg S, Miller C,
Pjanic M, Castano VG, Kim JB, Salfati EL, Kundaje AB, Bejerano G,
et al: Characterization of TCF21 downstream target regions
identifies a transcriptional network linking multiple independent
coronary artery disease loci. PLoS Genet.
11(e1005202)2015.PubMed/NCBI View Article : Google Scholar
|
